肌炎患者的心血管事件:法国回顾性队列研究结果
该研究为法国圣安托万大学医院的回顾性观察性队列研究,纳入1997至2020年78例特发性炎性肌炎患者;诊断时12例(15%)存在心脏受累,随访中15例(19%)发生心血管事件;诊断时有心脏受累者发生心血管事件的比例更高(50% vs 14%,p=0.01),且发生时间更早(中位9个月 vs 84个月,p<0.01)。
要点
- 诊断时存在心脏受累的肌炎患者心血管事件发生率更高(6例(50%)vs 9例(14%),p=0.01)。
- 诊断时有心脏受累者发生心血管事件的中位时间更短(9个月 vs 84个月,p<0.01)。
- 作者建议对诊断时有心脏受累的肌炎患者密切随访,尤其是诊断后最初数月。
核心结论
- 诊断时存在心脏受累的肌炎患者心血管事件风险增加且发生更早,应密切随访,尤其是诊断后最初数月。
研究设计与样本
- 法国巴黎圣安托万大学医院1997年至2020年的回顾性观察性队列研究,纳入78例特发性炎性肌炎患者。
主要发现
- 78例患者中位年龄49岁,67%为女性;33例(42%)为皮肌炎,18例(23%)为抗合成酶综合征,12例(15%)为重叠肌炎,11例(14%)为免疫介导坏死性肌病,4例(5%)为包涵体肌炎。
- 诊断时12例(15%)存在心脏受累,随访期间15例(19%)发生心血管事件。
- 诊断时有心脏受累者发生心血管事件的比例为6例(50%),无心脏受累者为9例(14%)(p=0.01)。
- 诊断时有心脏受累者发生心血管事件的中位时间(IQR)为9(0-34)个月,无心脏受累者为84(26-156)个月(p<0.01)。
关键数值与推荐
- 心脏受累定义为基线心电图、动态心电图、经胸超声心动图、心脏磁共振或心脏生物标志物升高提示的异常。
- 心血管事件定义为缺血导致的心力衰竭、心律失常或传导阻滞、炎性心肌炎或需入住复苏科室。
临床怎么用
- 作者建议对诊断时存在心脏受累的肌炎患者密切随访,尤其是诊断后最初数月。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Idiopathic inflammatory myositis (IIM) are systemic diseases, including dermatomyositis (DM), inclusion body myositis (IBM), immune-mediated necrotising myopathy (IMNM), antisynthetase syndrome (ASSD) and overlap myositis (OM). Patients with IIM have an increased risk of premature death, largely due to cardiovascular events (CVE). The aim of this study was to describe specific and non-specific cardiac involvement in patients with IIM, and to assess the occurrence of CVE. METHODS: We conducted a retrospective observational cohort study of patients with IIM from Saint Antoine University Hospital, Paris, between 1997 and 2020. Cardiac involvement was defined as abnormalities at baseline on ECG, Holter ECG, transthoracic echocardiography, cardiac MRI or elevated cardiac biomarkers. CVE were defined as heart failure due to ischaemia, arrhythmia or conductive block, inflammatory myocarditis or resuscitation department admission. RESULTS: 78 patients were included (median age 49 years; 67% female); 33 (42%) had DM, 18 (23%) ASSD, 12 (15%) OM, 11 (14%) IMNM and 4 (5%) IBM. Cardiac involvement at diagnosis was present in 12 (15%) patients; 15 (19%) had a CVE during follow-up. Patients with versus without cardiac involvement at diagnosis were more likely to present a CVE (6 (50%) vs 9 (14%); p=0.01). Median (IQR) time to CVE was shorter in patients with cardiac involvement (9 (0-34) vs 84 (26-156) months; p<0.01). CONCLUSION: Patients with cardiac involvement at myositis diagnosis are at increased risk of CVE and experience them earlier than patients without and should be carefully followed up, particularly during the first months after diagnosis.
引用
- Kasser C, Guédon AF, Allenbach Y, et al. Cardiovascular events in patients with myositis: results from a French retrospective cohort. RMD Open. 2025. PMID: 40081915. doi:10.1136/rmdopen-2024-005276
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。